Literature DB >> 19406830

GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling.

Andrew J Fleetwood1, Hang Dinh, Andrew D Cook, Paul J Hertzog, John A Hamilton.   

Abstract

M-CSF and GM-CSF are mediators involved in regulating the numbers and function of macrophage lineage populations and have been shown to contribute to macrophage heterogeneity. Type I IFN is an important mediator produced by macrophages and can have profound regulatory effects on their properties. In this study, we compared bone marrow-derived macrophages (BMM) and GM-CSF-induced BMM (GM-BMM) from wild-type and IFNAR1(-/-) mice to assess the contribution of endogenous type I IFN to the phenotypic differences between BMM and GM-BMM. BMM were capable of higher constitutive IFN-beta production, which contributed significantly to their basal transcriptome. Microarray analysis found that of the endogenous type I IFN-regulated genes specific to either BMM or GM-BMM, 488 of these gene alterations were unique to BMM, while only 50 were unique to GM-BMM. Moreover, BMM displayed enhanced basal mRNA levels, relative to GM-BMM, of a number of genes identified as being dependent on type I IFN signaling, including Stat1, Stat2, Irf7, Ccl5, Ccl12, and Cxcl10. As a result of prior type I IFN "priming," upon LPS stimulation BMM displayed increased activation of the MyD88-independent IRF-3/STAT1 pathways compared with GM-BMM, which correlated with the distinct cytokine/chemokine profiles of the two macrophage subsets. Furthermore, the autocrine type I IFN signaling loop regulated the production of the M1 and M2 signature cytokines, IL-12p70 and IL-10. Collectively, these findings demonstrate that constitutive and LPS-induced type I IFN play significant roles in regulating the differences in phenotype and function between BMM and GM-BMM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406830     DOI: 10.1189/jlb.1108702

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  126 in total

1.  Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration.

Authors:  Long V Ly; Inge H G Bronkhorst; Els van Beelen; Johannes Vrolijk; Andrew W Taylor; Mieke Versluis; Gregorius P M Luyten; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

2.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection.

Authors:  Takashi Satoh; Osamu Takeuchi; Alexis Vandenbon; Koubun Yasuda; Yoshiaki Tanaka; Yutaro Kumagai; Tohru Miyake; Kazufumi Matsushita; Toshihiko Okazaki; Tatsuya Saitoh; Kiri Honma; Toshifumi Matsuyama; Katsuyuki Yui; Tohru Tsujimura; Daron M Standley; Kenji Nakanishi; Kenta Nakai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-08-22       Impact factor: 25.606

3.  Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro.

Authors:  Ulrike Carolin Müller-Quernheim; Lars Potthast; Joachim Müller-Quernheim; Gernot Zissel
Journal:  J Interferon Cytokine Res       Date:  2012-01-26       Impact factor: 2.607

Review 4.  Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage.

Authors:  Irina Ushach; Albert Zlotnik
Journal:  J Leukoc Biol       Date:  2016-06-28       Impact factor: 4.962

5.  IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.

Authors:  Thomas Krausgruber; Katrina Blazek; Tim Smallie; Saba Alzabin; Helen Lockstone; Natasha Sahgal; Tracy Hussell; Marc Feldmann; Irina A Udalova
Journal:  Nat Immunol       Date:  2011-01-16       Impact factor: 25.606

6.  Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.

Authors:  C Andrew Stewart; Hannah Metheny; Noriho Iida; Loretta Smith; Miranda Hanson; Folkert Steinhagen; Robert M Leighty; Axel Roers; Christopher L Karp; Werner Müller; Giorgio Trinchieri
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

7.  Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation.

Authors:  Adrian Achuthan; Andrew D Cook; Ming-Chin Lee; Reem Saleh; Hsu-Wei Khiew; Melody W N Chang; Cynthia Louis; Andrew J Fleetwood; Derek C Lacey; Anne D Christensen; Ashlee T Frye; Pui Yeng Lam; Hitoshi Kusano; Koji Nomura; Nancy Steiner; Irmgard Förster; Stephen L Nutt; Moshe Olshansky; Stephen J Turner; John A Hamilton
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

8.  Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.

Authors:  Hui-Ming Chen; William van der Touw; Yuan Shuo Wang; Kyeongah Kang; Sunny Mai; Jilu Zhang; Dayanira Alsina-Beauchamp; James A Duty; Sathish Kumar Mungamuri; Bin Zhang; Thomas Moran; Richard Flavell; Stuart Aaronson; Hong-Ming Hu; Hisashi Arase; Suresh Ramanathan; Raja Flores; Ping-Ying Pan; Shu-Hsia Chen
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

9.  Klf10 inhibits IL-12p40 production in macrophage colony-stimulating factor-induced mouse bone marrow-derived macrophages.

Authors:  Wei Zhang; Xuelian Wang; Xiaoping Xia; Xia Liu; Shanshan Suo; Jing Guo; Min Li; Wenqiang Cao; Zhijian Cai; Zhaoyuan Hui; Malayannan Subramaniam; Thomas C Spelsberg; Jianli Wang; Lie Wang
Journal:  Eur J Immunol       Date:  2012-11-27       Impact factor: 5.532

10.  Functional crosstalk between type I and II interferon through the regulated expression of STAT1.

Authors:  Daniel J Gough; Nicole L Messina; Linda Hii; Jodee A Gould; Kanaga Sabapathy; Ashley P S Robertson; Joseph A Trapani; David E Levy; Paul J Hertzog; Christopher J P Clarke; Ricky W Johnstone
Journal:  PLoS Biol       Date:  2010-04-27       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.